(Q53976726)

23 May 2018

title

Insulin resistance and metabolic parameters in type 2 diabetic patients. (English)

1 reference

23 May 2018

1 reference

6

M Hanefeld

1 reference

23 May 2018

W Metzler

1

1 reference

23 May 2018

S Fischer

2

1 reference

23 May 2018

C Köhler

3

1 reference

23 May 2018

F Pistrosch

4

1 reference

23 May 2018

B Kindel

5

1 reference

23 May 2018

publication date

1 March 2002

1 reference

23 May 2018

European Journal of Internal Medicine

published in

1 reference

23 May 2018

volume

13

1 reference

23 May 2018

issue

2

1 reference

23 May 2018

page(s)

108-114

1 reference

23 May 2018

Insulin resistance in noninsulin-dependent diabetes mellitus. Does it exist and can it be measured?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900202-3

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900202-3

7 January 2021

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900202-3

7 January 2021

Reduced insulin-mediated glucose uptake by euglycemic clamp in offspring of patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900202-3

7 January 2021

Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon?

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900202-3

7 January 2021

Insulin action and secretion in healthy, glucose tolerant first degree relatives of patients with type 2 diabetes mellitus. Influence of body weight

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900202-3

7 January 2021

Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900202-3

7 January 2021

Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900202-3

7 January 2021

Exaggerated early insulin release and insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900202-3

7 January 2021

Assessment of insulin sensitivity in older adults using the hyperglycemic clamp technique.

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900202-3

7 January 2021

Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900202-3

7 January 2021

Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900202-3

7 January 2021

Insulin resistance and non-insulin-dependent diabetes mellitus: cellular and molecular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900202-3

7 January 2021

Impaired activation of glycogen synthase in people at increased risk for developing NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900202-3

7 January 2021

Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900202-3

7 January 2021

Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900202-3

7 January 2021

The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment results

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900202-3

7 January 2021

Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900202-3

7 January 2021

Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900202-3

7 January 2021

Pathophysiology of insulin resistance in human disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900202-3

7 January 2021

Effects of weight reduction on obesity. Studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900202-3

7 January 2021

Dyslipidaemias, insulin resistance and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900202-3

7 January 2021

Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state.

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900202-3

7 January 2021

Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900202-3

7 January 2021

Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status. Relation to plasma triglyceride and apolipoprotein B concentrations. Insulin Resistance Atherosclerosis Study (IRAS) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900202-3

7 January 2021

Insulin regulation of plasma free fatty acid concentrations is abnormal in healthy subjects with muscle insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900202-3

7 January 2021

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900202-3

7 January 2021

10.1016/S0953-6205(01)00202-3

Identifiers

DOI

1 reference

23 May 2018

1 reference

23 May 2018